novo nordisk weight loss - Search News

News

CEO of Novo Nordisk, Maker of Weight Loss Drug Wegovy

Associated Press News on MSN · 10h

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

The New York Times · 11h

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Novo Nordisk CEO's surprise exit after setbacks in weight-loss market: Reaction

Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

5h

Novo Nordisk announces CEO transition as share price slips

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...

5h

Eli Lilly pulls ahead of Novo in obesity drug gold rush as new players crowd in

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

6hon MSN

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

12hon MSN

Novo Nordisk CEO's Surprise Exit After Setbacks in Weight-Loss Market

"The Novo Nordisk Foundation is increasing its influence and has appointed its chairman, Lars Rebien Sørensen, as an observer ...

Indianapolis Business Journal2d

Novo Nordisk inks $2.2B deal to develop weight-loss pill to rival Lilly’s orforglipron

Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results